These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12672463)

  • 21. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
    Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
    J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
    Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
    Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits.
    Kessler BM; Tortorella D; Altun M; Kisselev AF; Fiebiger E; Hekking BG; Ploegh HL; Overkleeft HS
    Chem Biol; 2001 Sep; 8(9):913-29. PubMed ID: 11564559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages.
    Silva-Jardim I; Horta MF; Ramalho-Pinto FJ
    Acta Trop; 2004 Jul; 91(2):121-30. PubMed ID: 15234661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.
    da Costa CA; Ancolio K; Checler F
    Mol Med; 1999 Mar; 5(3):160-8. PubMed ID: 10404513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity.
    Guo X; Lin Y; Horbinski C; Drahushuk KM; Kim IJ; Kaplan PL; Lein P; Wang T; Higgins D
    J Neurobiol; 2001 Aug; 48(2):120-30. PubMed ID: 11438941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells.
    Nahreini P; Andreatta C; Prasad KN
    Cell Mol Neurobiol; 2001 Oct; 21(5):509-21. PubMed ID: 11860188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactacystin, proteasome function, and cell fate.
    Fenteany G; Schreiber SL
    J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
    Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
    J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway.
    Mezey E; Rennie-Tankersley L; Potter JJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
    Folco EJ; Koren G
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression.
    Salmena L; Lam V; McPherson JP; Goldenberg GJ
    Biochem Pharmacol; 2001 Apr; 61(7):795-802. PubMed ID: 11274964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
    Murray EJ; Bentley GV; Grisanti MS; Murray SS
    Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).
    Wilk S; Figueiredo-Pereira ME
    Enzyme Protein; 1993; 47(4-6):306-13. PubMed ID: 7697128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proteasome is involved in the first metaphase-to-anaphase transition of meiosis in rat oocytes.
    Josefsberg LB; Galiani D; Dantes A; Amsterdam A; Dekel N
    Biol Reprod; 2000 May; 62(5):1270-7. PubMed ID: 10775176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of phosphorylated neurofilaments and increase in apoptosis-specific protein and phosphorylated c-Jun induced by proteasome inhibitors.
    Masaki R; Saito T; Yamada K; Ohtani-Kaneko R
    J Neurosci Res; 2000 Oct; 62(1):75-83. PubMed ID: 11002289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasomal degradation of tau protein.
    David DC; Layfield R; Serpell L; Narain Y; Goedert M; Spillantini MG
    J Neurochem; 2002 Oct; 83(1):176-85. PubMed ID: 12358741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons.
    Qiu JH; Asai A; Chi S; Saito N; Hamada H; Kirino T
    J Neurosci; 2000 Jan; 20(1):259-65. PubMed ID: 10627603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.
    Chondrogianni N; Stratford FL; Trougakos IP; Friguet B; Rivett AJ; Gonos ES
    J Biol Chem; 2003 Jul; 278(30):28026-37. PubMed ID: 12736271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.